Julia Madsen - 02 Jun 2021 Form 4 Insider Report for STERIS plc (STE)

Role: Senior VP, Life Sciences
Signature: /s/ Ronald E. Snyder, Authorized Representative under Power of Attorney
Issuer symbol: STE
Transactions as of: 02 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 03 Jun 2021, 16:44:12 UTC
Previous filing: 02 Jun 2021
Next filing: 05 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	STE	Ordinary Shares	Award	$0	+1,440	+33%	$0.000000	5,857	02 Jun 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	STE	Employee Stock Option (right to buy)	Options Exercise	$0	+7,604		$0.000000	7,604	02 Jun 2021	Ordinary Shares	7,604	$210.30	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	All 1,440 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 360 on June 2, 2022; 360 on June 2, 2023; 360 on June 3, 2024 and 360 on June 2, 2025.
F2	3,510 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 349 on October 1, 2021; 121 on May 31, 2022; 92 on May 31, 2022; 123 on June 1, 2022; 360 on June 2, 2022; 349 on October 3, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 360 June 2, 2023; 349 on October 2, 2023; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024 and 360 on June 2, 2025.
F3	This option becomes exercisable as follows: 1,901 on June 2, 2022; 1,901 on June 2, 2023; 1,901 on June 3, 2024 and 1,901 on June 2, 2025.